ALPITERO

Serial Number 90203610
Registration 6799961
700

Registration Progress

Application Filed
Sep 23, 2020
Under Examination
Approved for Publication
May 10, 2022
Published for Opposition
May 10, 2022
Registered
Jul 26, 2022

Trademark Image

ALPITERO

Basic Information

Serial Number
90203610
Registration Number
6799961
Filing Date
September 23, 2020
Registration Date
July 26, 2022
Published for Opposition
May 10, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 26, 2022
Registration
Registered
Classes
005

Rights Holder

Eutilex Co., Ltd.

03
Address
Suite #408,
58, Gasan digital 1-ro, Geumcheon-gu,
Seoul 08591
KR

Ownership History

Eutilex Co., Ltd.

Original Applicant
03
Seoul KR

Eutilex Co., Ltd.

Owner at Publication
03
Seoul KR

Eutilex Co., Ltd.

Original Registrant
03
Seoul KR

Legal Representation

Attorney
Jong H Park

USPTO Deadlines

Next Deadline
993 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-07-26)
Due Date
July 26, 2028
Grace Period Ends
January 26, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Jul 26, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 26, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 10, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 10, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 20, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 21, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 21, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 21, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 21, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 16, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 16, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 15, 2022 ALIE A ASSIGNED TO LIE Loading...
Mar 14, 2022 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Feb 15, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Feb 15, 2022 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Feb 15, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Feb 14, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 14, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 14, 2022 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Aug 19, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 19, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 19, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 12, 2021 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Aug 12, 2021 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Aug 12, 2021 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Feb 12, 2021 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Feb 12, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Feb 12, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Feb 10, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 31, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 26, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer cells; living cells for medical or clinical use; pharmaceutical preparations for activating cellular function; biological preparations for the treatment of immune system related disorders; biological preparations for the treatment of cancer; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; vaccines; pharmaceutical preparations for the treatment of cancers with T cells; pharmaceutical preparations for the treatment of cancers with CAR-T cells

Classification

International Classes
005